Jingjing Yu

1.1k total citations · 1 hit paper
23 papers, 852 citations indexed

About

Jingjing Yu is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jingjing Yu has authored 23 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Oncology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jingjing Yu's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Jingjing Yu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Jingjing Yu collaborates with scholars based in United States, China and France. Jingjing Yu's co-authors include Isabelle Ragueneau‐Majlessi, Nina Isoherranen, Jennifer E. Sager, René H. Levy, Zhu Zhou, Tasha K. Ritchie, Yan Wang, Aditi Mulgaonkar, Anna Nordmark and Kai Dong and has published in prestigious journals such as Scientific Reports, Journal of Pharmaceutical Sciences and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jingjing Yu

22 papers receiving 828 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification

2015 384 citations Jennifer E. Sager, Jingjing Yu et al. Drug Metabolism and Disposition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingjing Yu United States	12	349	306	198	160	104	23	852
Eva Gil Berglund Sweden	13	466 1.3×	385 1.3×	259 1.3×	174 1.1×	154 1.5×	19	1.1k
Yuan Chen United States	17	520 1.5×	537 1.8×	269 1.4×	261 1.6×	109 1.0×	62	1.4k
Shirley M. Tsunoda United States	17	461 1.3×	316 1.0×	261 1.3×	226 1.4×	126 1.2×	47	1.1k
Oliver Hatley United Kingdom	16	324 0.9×	297 1.0×	145 0.7×	206 1.3×	91 0.9×	27	952
Zoe Barter United Kingdom	14	586 1.7×	473 1.5×	247 1.2×	166 1.0×	136 1.3×	17	1.1k
Kellie S. Reynolds United States	15	535 1.5×	372 1.2×	216 1.1×	190 1.2×	183 1.8×	31	1.1k
Pradeep Sharma United Kingdom	20	290 0.8×	468 1.5×	259 1.3×	201 1.3×	135 1.3×	45	1.0k
Xinning Yang United States	15	287 0.8×	640 2.1×	255 1.3×	335 2.1×	125 1.2×	36	1.2k
Upendra A. Argikar United States	19	478 1.4×	310 1.0×	258 1.3×	406 2.5×	123 1.2×	55	1.2k
K S Reynolds United States	6	290 0.8×	273 0.9×	167 0.8×	121 0.8×	87 0.8×	8	707

Countries citing papers authored by Jingjing Yu

Since Specialization

Citations

This map shows the geographic impact of Jingjing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Yu more than expected).

Fields of papers citing papers by Jingjing Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingjing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Yu. The network helps show where Jingjing Yu may publish in the future.

Co-authorship network of co-authors of Jingjing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingjing Yu. A scholar is included among the top collaborators of Jingjing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingjing Yu. Jingjing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Jingjing, et al.. (2025). Immunoinformatics method to design universal multi-epitope nanoparticle vaccine for TGEV S protein. Scientific Reports. 15(1). 10931–10931. 2 indexed citations

Yu, Jingjing, et al.. (2025). GALNT4-induced O-GalNAc glycosylation of MUC1 accelerates the invasive phenotype of PDAC. Pancreatology. 25(6). 939–949.

Yu, Jingjing, et al.. (2024). Risk of Enzyme- and Transporter-mediated Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews. Clinical Therapeutics. 46(6). 499–508. 5 indexed citations

Yu, Jingjing, et al.. (2024). Metabolite Measurement in Index Substrate Drug Interaction Studies: A Review of the Literature and Recent New Drug Application Reviews. Metabolites. 14(10). 522–522. 1 indexed citations

Yu, Jingjing, Yan Wang, & Isabelle Ragueneau‐Majlessi. (2022). Strong Pharmacokinetic Drug-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2021: Mechanisms and Clinical Implications. Clinical Therapeutics. 44(11). 1536–1544. 16 indexed citations

Yu, Jingjing, et al.. (2021). Exploring the Relationship of Drug BCS Classification, Food Effect, and Gastric pH-Dependent Drug Interactions. The AAPS Journal. 24(1). 16–16. 11 indexed citations

Yu, Jingjing, Yan Wang, & Isabelle Ragueneau‐Majlessi. (2021). Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical Recommendations. Drug Metabolism and Disposition. 50(1). 1–7. 28 indexed citations

Yang, Xinning, et al.. (2021). Do Inhibitory Metabolites Impact DDI Risk Assessment? Analysis of in vitro and in vivo Data from NDA Reviews Between 2013 and 2018. Clinical Pharmacology & Therapeutics. 110(2). 452–463. 9 indexed citations

Ritchie, Tasha K., Jingjing Yu, Anna Nordmark, et al.. (2020). Inhibitors of Organic Anion‐Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective. The Journal of Clinical Pharmacology. 60(8). 1087–1098. 4 indexed citations

10.

Yu, Jingjing & Isabelle Ragueneau‐Majlessi. (2020). In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018. Clinical and Translational Science. 13(4). 693–699. 11 indexed citations

11.

Yu, Jingjing, Ping Zhao, Susan Hershenson, et al.. (2019). Drug–Drug Interactions of Infectious Disease Treatments in Low‐Income Countries: A Neglected Topic?. Clinical Pharmacology & Therapeutics. 105(6). 1378–1385. 3 indexed citations

12.

Li, Jian, Olajide E. Olaleye, Xuan Yu, et al.. (2019). High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care. Acta Pharmaceutica Sinica B. 9(5). 1035–1049. 29 indexed citations

13.

Yu, Jingjing, et al.. (2018). Risk of Clinically Relevant Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration Between 2013 and 2016. Drug Metabolism and Disposition. 46(6). 835–845. 72 indexed citations

14.

Ritchie, Tasha K., et al.. (2018). Identification and evaluation of clinical substrates of organic anion transporting polypeptides 1B1 and 1B3. Drug Metabolism and Pharmacokinetics. 33(1). S19–S19. 1 indexed citations

15.

Yu, Jingjing, et al.. (2018). Mechanisms and Clinical Significance of Pharmacokinetic-Based Drug-Drug Interactions with Drugs Approved by the U.S. Food and Drug Administration in 2017. Drug Metabolism and Disposition. 47(2). 135–144. 70 indexed citations

16.

Yu, Jingjing, et al.. (2017). Intestinal Drug Interactions Mediated by OATPs: A Systematic Review of Preclinical and Clinical Findings. Journal of Pharmaceutical Sciences. 106(9). 2312–2325. 96 indexed citations

17.

Yu, Jingjing, et al.. (2016). Research progress in anti-cardiovascular and cerebrovascular disease activity of Citri Reticulatae Pericarpium. Zhongcaoyao. 47(17). 3127–3132. 3 indexed citations

18.

Yu, Jingjing, et al.. (2016). What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015. Drug Metabolism and Disposition. 45(1). 86–108. 38 indexed citations

19.

Sager, Jennifer E., Jingjing Yu, Isabelle Ragueneau‐Majlessi, & Nina Isoherranen. (2015). Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification. Drug Metabolism and Disposition. 43(11). 1823–1837. 384 indexed citations breakdown →

20.

Yu, Jingjing, Tasha K. Ritchie, Aditi Mulgaonkar, & Isabelle Ragueneau‐Majlessi. (2014). Drug Disposition and Drug-Drug Interaction Data in 2013 FDA New Drug Applications: A Systematic Review. Drug Metabolism and Disposition. 42(12). 1991–2001. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact